巴瑞克替尼是一种治疗类风湿性关节炎(RA)的药物,是由英格尔和伊莉莉开发的。它作为JAK激酶的抑制剂,阻断JAK1和JAK2亚型。该药在欧洲获得批准。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
Diphenylmethanamine
-
BD4210191-00-998%
-
¥73.00100g常备现货
-
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine
-
BD204803680-69-198%
-
¥31.005g常备现货
-
2-(Trimethylsilyl)ethoxymethyl Chloride
-
BD3487476513-69-490% (stabilized with Diisopropylethylamine)
-
¥40.005g常备现货
-
4-(1-(1-Ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
-
BD6264961187595-88-597%
-
¥482.00250mg常备现货
-
tert-Butyl 3-hydroxyazetidine-1-carboxylate
-
BD5476141699-55-098%
-
¥399.00100g常备现货
-
tert-Butyl 3-(cyanomethylene)azetidine-1-carboxylate
-
BD2172341153949-11-198%
-
¥776.00100g常备现货
-
1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
-
BD1962531029716-44-695%
-
¥18.00250mg常备现货
-
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
-
BD196746941685-26-398%
-
¥175.005g常备现货
-
2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
-
BD2644841187594-09-799%
-
¥56.00250mg常备现货
-
tert-Butyl 3-oxoazetidine-1-carboxylate
-
BD28609398489-26-498%
-
¥85.0025g常备现货
-
1-Benzhydrylazetidin-3-ol
-
BD1902718621-17-598%
-
¥23.005g常备现货
-
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
-
BD007701441187594-13-3
-
¥4802.0025g